ROME Therapeutics, Enara Bio, Nucleome Therapeutics and NYU Langone Health to Host 3rd Annual Dark Genome Symposium
October 08, 2024 05:00 ET
|
Rome Therapeutics, Inc.
ROME Therapeutics, Enara Bio, Nucleome Therapeutics and NYU Langone Health will host the 3rd Annual Dark Genome Symposium on Nov. 21 - 22 in New York, NY.
ROME Therapeutics to Participate in 2024 Cantor Global Healthcare Conference
September 11, 2024 07:00 ET
|
Rome Therapeutics, Inc.
BOSTON, Sept. 11, 2024 (GLOBE NEWSWIRE) -- ROME Therapeutics, a biotechnology company harnessing the power of the dark genome to develop breakthrough medicines for serious diseases, today announced...
ROME Therapeutics to Participate in 2024 Wedbush PacGrow Healthcare Conference
August 12, 2024 07:00 ET
|
Rome Therapeutics, Inc.
ROME Therapeutics' President, CEO and Co-Founder, Rosana Kapeller, M.D., Ph.D., will participate in the 2024 Wedbush PacGrow Healthcare Conference.